UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The effects of increasing body mass index on heartburn severity, frequency and response to treatment with dexlansoprazole or lansoprazole

Alimentary pharmacology & therapeutics, 2013-04, Vol.37 (8), p.810-818

2013

Volltextzugriff (PDF)

Risk factors associated with a decrease ≥2 g/dL in haemoglobin and/or ≥10% haematocrit in osteoarthritis patients taking celecoxib or a nonselective NSAID plus a PPI in a large randomised controlled trial (CONDOR)

Alimentary pharmacology & therapeutics, 2012-09, Vol.36 (5), p.485-492

2012

Volltextzugriff (PDF)

Distinguishing the impact of dexlansoprazole on heartburn vs. regurgitation in patients with gastro‐oesophageal reflux disease

Alimentary pharmacology & therapeutics, 2013-11, Vol.38 (10), p.1303-1311

2013

Volltextzugriff (PDF)

The clinical safety of long‐term lansoprazole for the maintenance of healed erosive oesophagitis

Alimentary pharmacology & therapeutics, 2009-06, Vol.29 (12), p.1249-1260

2009

Volltextzugriff (PDF)

Safety profile of dexlansoprazole MR, a proton pump inhibitor with a novel dual delayed release formulation: global clinical trial experience

Alimentary pharmacology & therapeutics, 2009-11, Vol.30 (10), p.1010-1021

2009

Volltextzugriff (PDF)

Clinical trial: lansoprazole 15 or 30 mg once daily vs. placebo for treatment of frequent nighttime heartburn in self‐treating subjects

Alimentary pharmacology & therapeutics, 2009-09, Vol.30 (5), p.459-468

2009

Volltextzugriff (PDF)

Changes of gastric histology in patients with erosive oesophagitis receiving long‐term lansoprazole maintenance therapy

Alimentary pharmacology & therapeutics, 2010-07, Vol.32 (1), p.83-96

2010

Volltextzugriff (PDF)

The 12‐month safety profile of dexlansoprazole, a proton pump inhibitor with a dual delayed release formulation, in patients with gastro‐oesophageal reflux disease

Alimentary pharmacology & therapeutics, 2011-02, Vol.33 (3), p.366-377

2011

Volltextzugriff (PDF)

The American college of gastroenterology bleeding registry : Preliminary findings

The American journal of gastroenterology, 1997-06, Vol.92 (6), p.924-928

1997

Volltextzugriff (PDF)

Usefulness of serological IgG antibody determinations for confirming eradication of Helicobacter pylori infection

The American journal of gastroenterology, 1999-08, Vol.94 (8), p.2105-2108

1999

Volltextzugriff (PDF)

Diagnosis of Helicobacter pylori infection: Helicobacter pylori infection

Gastroenterology clinics of North America, 1993-03, Vol.22 (1), p.105-115

1993

Volltextzugriff (PDF)

Prevalence of gastric myoelectrical abnormalities in patients with nonulcer dyspepsia and H. pylori infection: Resolution after H. pylori eradication

Digestive diseases and sciences, 2001-04, Vol.46 (4), p.739-745

2001

Volltextzugriff (PDF)

Comparison of Prilosec OTC (omeprazole magnesium 20.6 mg) to placebo for 14 days in the treatment of frequent heartburn

Journal of clinical pharmacy and therapeutics, 2005-04, Vol.30 (2), p.105-112

2005

Volltextzugriff (PDF)

Nasogastric omeprazole : Effects on gastric pH in critically ill patients

The American journal of gastroenterology, 1997, Vol.92 (1), p.79-83

1997

Volltextzugriff (PDF)

Cimetidine for prevention and treatment of gastroduodenal mucosal lesions in patients in an intensive care unit

Annals of internal medicine, 1985-08, Vol.103 (2), p.173

1985

Volltextzugriff (PDF)

Salivary and gastric epidermal growth factor in patients with Zollinger-Ellison syndrome: its protective potential

The American journal of gastroenterology, 2000-05, Vol.95 (5), p.1158-1165

2000

Volltextzugriff (PDF)

Balancing the gastrointestinal benefits and risks of nonselective NSAIDs

Arthritis research & therapy, 2005-01, Vol.7 Suppl 4 (Suppl 4), p.S7-S13

2005

Volltextzugriff (PDF)

Gastroduodenal mucus gel thickness in patients with Helicobacter pylori : a method for assessment of biopsy specimens

The American journal of gastroenterology, 1991-06, Vol.86 (6), p.729-734

1991

Volltextzugriff (PDF)

Gastrointestinal disorders are among the most common disorders encountered in the United States and Europe

Alimentary pharmacology & therapeutics, 2004-02, Vol.19 Suppl 1, p.v-v

2004

Volltextzugriff (PDF)

Helicobacter pylori-related disease: guidelines for testing and treatment

Archives of internal medicine (1960), 2000-05, Vol.160 (9), p.1285

2000

Volltextzugriff (PDF)

Stress ulcer bleeding: hopeful optimism

The American journal of medicine, 1998-04, Vol.104 (4), p.404-405

1998

Volltextzugriff (PDF)

Campylobacter pylori, NSAIDS, and smoking: risk factors for peptic ulcer disease

The American journal of gastroenterology, 1989-10, Vol.84 (10), p.1268-1272

1989

Volltextzugriff (PDF)

The relationship between the content of aggressive and protective components in gastric juice and endoscopic findings after naproxen sodium and acetaminophen administration

The American journal of gastroenterology, 1996-02, Vol.91 (2), p.360-365

1996

Volltextzugriff (PDF)

Impact of Helicobacter pylori colonization on immunoreactive epidermal growth factor and transforming growth factor-α in gastric juice : Its potential pathogenetic implications

Digestive diseases and sciences, 1996-11, Vol.41 (11), p.2150-2155

1996

Volltextzugriff (PDF)

Topical therapy for the control of gastrointestinal bleeding

Gastrointestinal endoscopy, 1990-09, Vol.36 (5), p.S53-S55

PEURA, D. A

1990

Volltextzugriff (PDF)

1 – 25 von 371

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(303)
Mit Volltextzugriff
(299)

Publikationsform

Sprache

Englisch
(370)

Erscheinungsjahr

n.n

Thema

Science & Technology
(190)
Life Sciences & Biomedicine
(128)
Humans
(124)
Physics
(80)
Biological And Medical Sciences
(75)
Female
(68)
Medical Sciences
(68)
Male
(67)
Gastroenterology & Hepatology
(61)
Physical Sciences
(60)
Middle Aged
(55)
Adult
(53)
Physics, Nuclear
(47)
Aged
(35)
Gastroenterology. Liver. Pancreas. Abdomen
(31)
Helicobacter Pylori
(25)
Technology
(23)
Other Diseases. Semiology
(21)
Nuclei
(20)
Pharmacology. Drug Treatments
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

The effects of increasing body mass index on heartburn severity, frequency and response to treatment with dexlansoprazole or lansoprazole

Risk factors associated with a decrease ≥2 g/dL in haemoglobin and/or ≥10% haematocrit in osteoarthritis patients taking celecoxib or a nonselective NSAID plus a PPI in a large randomised controlled trial (CONDOR)

Distinguishing the impact of dexlansoprazole on heartburn vs. regurgitation in patients with gastro‐oesophageal reflux disease

The clinical safety of long‐term lansoprazole for the maintenance of healed erosive oesophagitis

Safety profile of dexlansoprazole MR, a proton pump inhibitor with a novel dual delayed release formulation: global clinical trial experience

Clinical trial: lansoprazole 15 or 30 mg once daily vs. placebo for treatment of frequent nighttime heartburn in self‐treating subjects

Changes of gastric histology in patients with erosive oesophagitis receiving long‐term lansoprazole maintenance therapy

The 12‐month safety profile of dexlansoprazole, a proton pump inhibitor with a dual delayed release formulation, in patients with gastro‐oesophageal reflux disease

The American college of gastroenterology bleeding registry : Preliminary findings

Usefulness of serological IgG antibody determinations for confirming eradication of Helicobacter pylori infection

Diagnosis of Helicobacter pylori infection: Helicobacter pylori infection

Prevalence of gastric myoelectrical abnormalities in patients with nonulcer dyspepsia and H. pylori infection: Resolution after H. pylori eradication

Comparison of Prilosec OTC (omeprazole magnesium 20.6 mg) to placebo for 14 days in the treatment of frequent heartburn

Nasogastric omeprazole : Effects on gastric pH in critically ill patients

Cimetidine for prevention and treatment of gastroduodenal mucosal lesions in patients in an intensive care unit

Salivary and gastric epidermal growth factor in patients with Zollinger-Ellison syndrome: its protective potential

Balancing the gastrointestinal benefits and risks of nonselective NSAIDs

Gastroduodenal mucus gel thickness in patients with Helicobacter pylori : a method for assessment of biopsy specimens

Gastrointestinal disorders are among the most common disorders encountered in the United States and Europe

Helicobacter pylori-related disease: guidelines for testing and treatment

Stress ulcer bleeding: hopeful optimism

Campylobacter pylori, NSAIDS, and smoking: risk factors for peptic ulcer disease

The relationship between the content of aggressive and protective components in gastric juice and endoscopic findings after naproxen sodium and acetaminophen administration

Impact of Helicobacter pylori colonization on immunoreactive epidermal growth factor and transforming growth factor-α in gastric juice : Its potential pathogenetic implications

Topical therapy for the control of gastrointestinal bleeding

Suchergebnisse filtern